The levels of superoxide anion and NADPH oxidase activity in the hypothalamus of rats in the DCXD-5 and DCXD-2.5 groups were significantly lower (P < 0.01) than the model group, but not in the AML group. This evidence concerns the gene FMO5 and acute myeloid leukemia.